Our Board

Dr. Laura M. Bogart
Dr. Laura M. Bogart, PhD, is a Senior Behavior Scientist at the RAND Corporation. She is a social psychologist with expertise in HIV disparities, including psychosocial factors in HIV prevention and adherence, and development and testing of behavioral HIV interventions. Her primary research impact has been in the areas of stigma and medical mistrust, especially among Black/African Americans and Latinos. She conducts behavioral HIV research in the U.S., as well as in Sub-Saharan Africa (Botswana, South Africa, and Uganda). She is a Fellow in both the American Psychological Association and the Society of Behavioral Medicine. In 2014, she was awarded the American Psychological Association’s Division 44 (LGBT Psychology) Award for Distinguished Contribution to Ethnic Minority Issues

Dr. Sheana Bull
Dr. Sheana Bull received her B.A. in International Relations from the University of California, Davis, a Master’s in Public Health from Tulane University School of Public Health and Tropical Medicine, and a PhD in Sociology from Georgia State University. She joined the Faculty in the School of Medicine at the University of Colorado in 2002 and became a founding Faculty member in the Colorado School of Public Health in 2006, where she retains a Faculty position. Her research is focused on testing and determining the efficacy of interventions for health promotion and chronic condition self-management using mobile and social media technologies. She has led and collaborated on numerous federal research grants demonstrating the effects of using the Internet, social media, text messaging and apps to address HIV, Sexually Transmitted Infections, teen pregnancy prevention and chronic illness. She directa the mHealth Impact Laboratory at the University of Colorado, intended to shorten the timeline to establish the efficacy of mHealth solutions, to curate effective mHealth solutions and facilitate their widespread dissemination and scale.

Dr. Robert Garofalo
Dr. Robert Garofalo is a Professor of Pediatrics and Preventive Medicine at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. He is also an attending physician at the Ann & Robert H. Lurie Children’s Hospital, where he serves as the Director of the Research Center of Excellence for Gender, Sexuality, and HIV Prevention and as the Division Chief of Adolescent Medicine. He co-directs the gender and sexual development clinical program at Lurie Children’s Hospital — the first comprehensive program providing multidisciplinary care to transgender/gender-nonconforming children and adolescents in the Midwest. His research focuses on HIV prevention, mostly targeting either young men who have sex with men (MSM) or transgender individuals. He has more than 25 years of research experience in this field and is a national authority on LGBT health issues, adolescent sexuality, and HIV clinical care and prevention. In 2010, he was appointed to the National Academy of Science/ Institute of Medicine on LGBT Health Issues and Research Gaps and Opportunities. Dr. Garofalo’s research has been generously funded by the National Institutes of Health. He is or has been the Principal Investigator on 13 NIH-funded Investigator initiated research grants and a Co-Investigator on an additional 14 other NIH-funded research projects. He is currently a member of a number of professional organizations and scientific associations including the American Academy of Pediatrics, the Society for Adolescent Medicine, the American Medical Association, and the World Professional Association for Transgender Health. Dr. Garofalo is the Editor-in-Chief of the journal Transgender Health. He has over 150 publications in scholarly journals. In addition to his academic work, Dr. Garofalo is founder of Fred Says (named after his dog), a 501©3 non-profit charity that since 2013 has raised and donated back to the community over $300.000 to support care and services for HIV+ youth.

Former Board Members